4 Results for "

HLA-A2.1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "HLA-A2.1" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-P1778A
Target:  

HPV

Research Areas:  

Infection

HPV16 E7 (86-93) TFA is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) TFA is immunogenic in cervical carcinomas .
loading...
    loading...
Cat. No.: HY-P1827
CAS No.: 219312-69-3
Target:  

Tyrosinase MHC

Research Areas:  

Cancer

mTRP-2 (180-188) is an MHC class I-restricted tumor-associated antigenic peptide derived from mouse tyrosinase-related protein 2 (TRP-2). mTRP-2 (180-188) binds to HLA-A*0201 with an ID50 of 36 nM. mTRP-2 (180-188) can be presented by H-2K b molecules and activate TRP-2-specific cytotoxic T lymphocytes (CTL). mTRP-2 (180-188) induces immune responses against B16 melanoma by promoting antigen-specific T cell proliferation, cytokine release, and CTL-mediated tumor cell killing. mTRP-2 (180-188) can be used in studies related to melanoma, glioma, and tumor immunology .
loading...
    loading...
Cat. No.: HY-P1919
CAS No.: 168650-46-2
Target:  

Tyrosinase

Research Areas:  

Cancer

Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy .
loading...
    loading...
Cat. No.: HY-P1778
CAS No.: 160212-93-1
Target:  

HPV

Research Areas:  

Infection

HPV16 E7 (86-93) is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) is immunogenic in cervical carcinomas .
loading...
    loading...